serw-MX  [xml]  
 


    
 DeCS Categories

D02 Organic Chemicals .
D02.886 Sulfur Compounds .
D02.886.675 Thiazoles .
D02.886.675.414 Lurasidone Hydrochloride .
D03 Heterocyclic Compounds .
D03.383 Heterocyclic Compounds, 1-Ring .
D03.383.129 Azoles .
D03.383.129.385 Isoxazoles .
D03.383.129.385.650 Paliperidone Palmitate .
D03.383.129.708 Thiazoles .
D03.383.129.708.414 Lurasidone Hydrochloride .
D03.383.606 Piperazines .
D03.383.606.170 Aripiprazole .
D03.383.742 Pyrimidines .
D03.383.742.592 Paliperidone Palmitate .
D03.383.742.698 Pyrimidinones .
D03.383.742.698.685 Risperidone .
D03.633 Heterocyclic Compounds, Fused-Ring .
D03.633.100 Heterocyclic Compounds, 2-Ring .
D03.633.100.513 Isoindoles .
D03.633.100.513.437 Lurasidone Hydrochloride .
D03.633.100.810 Quinolines .
D03.633.100.810.835 Quinolones .
D03.633.100.810.835.122 Aripiprazole .
D06 Hormones, Hormone Substitutes, and Hormone Antagonists .
D06.347 Hormone Antagonists .
D06.347.065 Androgen Antagonists .
D06.347.065.249 Androgen Receptor Antagonists .
D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.519 Molecular Mechanisms of Pharmacological Action .
D27.505.519.625 Neurotransmitter Agents .
D27.505.519.625.150 Dopamine Agents .
D27.505.519.625.150.175 Dopamine Antagonists .
D27.505.519.625.150.175.500 Dopamine D2 Receptor Antagonists .
D27.505.519.625.850 Serotonin Agents .
D27.505.519.625.850.850 Serotonin Antagonists .
D27.505.519.625.850.850.200 Serotonin 5-HT2 Receptor Antagonists .
D27.505.696 Physiological Effects of Drugs .
D27.505.696.399 Hormones, Hormone Substitutes, and Hormone Antagonists .
D27.505.696.399.450 Hormone Antagonists .
D27.505.696.399.450.065 Androgen Antagonists .
D27.505.696.399.450.065.249 Androgen Receptor Antagonists .
D27.505.696.577 Neurotransmitter Agents .
D27.505.696.577.150 Dopamine Agents .
D27.505.696.577.150.175 Dopamine Antagonists .
D27.505.696.577.150.175.500 Dopamine D2 Receptor Antagonists .
D27.505.696.577.850 Serotonin Agents .
D27.505.696.577.850.850 Serotonin Antagonists .
D27.505.696.577.850.850.200 Serotonin 5-HT2 Receptor Antagonists .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Paliperidone Palmitate .
3-(2-(4-(6-fluoro-3-(1,2-benzisoxazolyl))-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one .
9-Hydroxy-risperidone .
9-Hydroxyrisperidone .
9-OH-risperidone .
Invega .
Invega Sustenna .
Paliperidone .
R 76477 .
R-76477 .
9 Hydroxy risperidone .
9 Hydroxyrisperidone .
9 OH risperidone .
Palmitate, Paliperidone .
R76477 .
Sustenna, Invega .
A benzisoxazole derivative and active metabolite of RISPERIDONE that functions as a DOPAMINE D2 RECEPTOR ANTAGONIST and SEROTONIN 5-HT2 RECEPTOR ANTAGONIST. It is an ANTIPSYCHOTIC AGENT used in the treatment of SCHIZOPHRENIA. .
1.00
 
Aripiprazole .
7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone .
Abilify .
Aripiprazol .
OPC 14597 .
OPC-14597 .
14597, OPC .
An antipsychotic agent that is structurally related to piperazines and quinolones. It is a partial agonist of SEROTONIN RECEPTOR, 5-HT1A and DOPAMINE D2 RECEPTORS, where it also functions as a post-synaptic antagonist, and an antagonist of SEROTONIN RECEPTOR, 5-HT2A. .
0.66
 
Risperidone .
R-64,766 .
R-64766 .
Risperdal Consta .
Risperidal .
Consta, Risperdal .
R 64,766 .
R 64766 .
R64,766 .
R64766 .
A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA. .
0.63
 
Lurasidone Hydrochloride .
Latuda .
Lurasidone .
Lurasidone HCl .
N-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinylmethyl)-1-cyclohexylmethyl)-2,3-bicyclo(2.2.1)heptanedicarboximide .
SM 13496 .
SM-13,496 .
SM-13496 .
SM13496 .
13496, SM .
HCl, Lurasidone .
Hydrochloride, Lurasidone .
SM 13,496 .
SM13,496 .
A thiazole derivative and atypical ANTIPSYCHOTIC AGENT that functions as a DOPAMINE D2 RECEPTOR ANTAGONIST; SEROTONIN 5-HT2 RECEPTOR ANTAGONIST, serotonin 5-HT7 receptor antagonist, and antagonist of the adrenergic alpha2A and alpha2C receptors, as well as a partial SEROTONIN 5-HT1A RECEPTOR AGONIST. It is used in the treatment of SCHIZOPHRENIA and BIPOLAR DISORDER. .
0.61
 
Androgen Receptor Antagonists .
Antagonists, Androgen Receptor .
Receptor Antagonists, Androgen .
Compounds that bind to and inhibit the activation of ANDROGEN RECEPTORS. .
0.54
 
Dopamine D2 Receptor Antagonists .
Dopamine D2 Antagonists .
Receptor Antagonists, Dopamine D2 .
Antagonists, Dopamine D2 .
D2 Antagonists, Dopamine .
Compounds and drugs that bind to and inhibit or block the activation of DOPAMINE D2 RECEPTORS. .
0.53
 
Serotonin 5-HT2 Receptor Antagonists .
5-HT2 Antagonist .
5-HT2A Antagonist .
5-HT2B Antagonist .
5-HT2C Antagonist .
Serotonin 5-HT2A Receptor Antagonists .
Serotonin 5-HT2B Receptor Antagonists .
Serotonin 5-HT2C Receptor Antagonists .
5 HT2 Antagonist .
5 HT2A Antagonist .
5 HT2B Antagonist .
5 HT2C Antagonist .
Antagonist, 5-HT2 .
Antagonist, 5-HT2A .
Antagonist, 5-HT2B .
Antagonist, 5-HT2C .
Serotonin 5 HT2 Receptor Antagonists .
Serotonin 5 HT2A Receptor Antagonists .
Serotonin 5 HT2B Receptor Antagonists .
Serotonin 5 HT2C Receptor Antagonists .
Drugs that bind to but do not activate SEROTONIN 5-HT2 RECEPTORS, thereby blocking the actions of SEROTONIN or SEROTONIN 5-HT2 RECEPTOR AGONISTS. Included under this heading are antagonists for one or more specific 5-HT2 receptor subtypes. .
0.52